Scoop: Famed can­cer re­searcher — and biotech founder — Lew Cant­ley is head­ed to Dana-Far­ber

Lew Cant­ley, the famed can­cer re­searcher best known for his dis­cov­ery of the PI3K path­way and his ground­break­ing work on can­cer me­tab­o­lism, is head­ed to Dana-Far­ber.

We got tipped off by some­one at the in­sti­tute that Cant­ley will make his move from Weill Cor­nell Med­i­cine next Feb­ru­ary af­ter Dana-Far­ber chief Lau­rie Glim­ch­er sent out a note herald­ing his im­pend­ing ar­rival as a fac­ul­ty mem­ber in the De­part­ment of Can­cer Bi­ol­o­gy. That puts the ex-Har­vard pro­fes­sor right back in the cen­ter of things dur­ing an un­prece­dent­ed biotech boom that has put Cam­bridge/Boston right at the epi­cen­ter of drug R&D.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER